514 related articles for article (PubMed ID: 21901321)
21. Nicotinic receptors mediate stress-nicotine detrimental interplay via dopamine cells' activity.
Morel C; Fernandez SP; Pantouli F; Meye FJ; Marti F; Tolu S; Parnaudeau S; Marie H; Tronche F; Maskos U; Moretti M; Gotti C; Han MH; Bailey A; Mameli M; Barik J; Faure P
Mol Psychiatry; 2018 Jul; 23(7):1597-1605. PubMed ID: 29155800
[TBL] [Abstract][Full Text] [Related]
22. Role of α6-Nicotinic Receptors in Alcohol-Induced GABAergic Synaptic Transmission and Plasticity to Cholinergic Interneurons in the Nucleus Accumbens.
Wadsworth HA; Anderson EQ; Williams BM; Ronström JW; Moen JK; Lee AM; McIntosh JM; Wu J; Yorgason JT; Steffensen SC
Mol Neurobiol; 2023 Jun; 60(6):3113-3129. PubMed ID: 36802012
[TBL] [Abstract][Full Text] [Related]
23. Nicotine potentiation of excitatory inputs to ventral tegmental area dopamine neurons.
Mao D; Gallagher K; McGehee DS
J Neurosci; 2011 May; 31(18):6710-20. PubMed ID: 21543600
[TBL] [Abstract][Full Text] [Related]
24. Nicotine enhances responding for conditioned reinforcement via α4β2 nicotinic acetylcholine receptors in the ventral tegmental area, but not the nucleus accumbens or the prefrontal cortex.
Tabbara RI; Fletcher PJ
Neuropharmacology; 2019 Apr; 148():68-76. PubMed ID: 30550794
[TBL] [Abstract][Full Text] [Related]
25. Distinct Temporal Structure of Nicotinic ACh Receptor Activation Determines Responses of VTA Neurons to Endogenous ACh and Nicotine.
Morozova E; Faure P; Gutkin B; Lapish C; Kuznetsov A
eNeuro; 2020; 7(4):. PubMed ID: 32737187
[TBL] [Abstract][Full Text] [Related]
26. Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug.
Baker LK; Mao D; Chi H; Govind AP; Vallejo YF; Iacoviello M; Herrera S; Cortright JJ; Green WN; McGehee DS; Vezina P
Eur J Neurosci; 2013 Mar; 37(6):1004-11. PubMed ID: 23331514
[TBL] [Abstract][Full Text] [Related]
27. Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effects.
Tan H; Bishop SF; Lauzon NM; Sun N; Laviolette SR
Neuropharmacology; 2009 Mar; 56(4):741-51. PubMed ID: 19133278
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms involved in systemic nicotine-induced glutamatergic synaptic plasticity on dopamine neurons in the ventral tegmental area.
Gao M; Jin Y; Yang K; Zhang D; Lukas RJ; Wu J
J Neurosci; 2010 Oct; 30(41):13814-25. PubMed ID: 20943922
[TBL] [Abstract][Full Text] [Related]
29. Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction.
Pidoplichko VI; Noguchi J; Areola OO; Liang Y; Peterson J; Zhang T; Dani JA
Learn Mem; 2004; 11(1):60-9. PubMed ID: 14747518
[TBL] [Abstract][Full Text] [Related]
30. Putative role of presynaptic alpha7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area.
Schilström B; Fagerquist MV; Zhang X; Hertel P; Panagis G; Nomikos GG; Svensson TH
Synapse; 2000 Dec; 38(4):375-83. PubMed ID: 11044884
[TBL] [Abstract][Full Text] [Related]
31. Functional nicotinic acetylcholine receptors containing α6 subunits are on GABAergic neuronal boutons adherent to ventral tegmental area dopamine neurons.
Yang K; Buhlman L; Khan GM; Nichols RA; Jin G; McIntosh JM; Whiteaker P; Lukas RJ; Wu J
J Neurosci; 2011 Feb; 31(7):2537-48. PubMed ID: 21325521
[TBL] [Abstract][Full Text] [Related]
32. Catharanthine Modulates Mesolimbic Dopamine Transmission and Nicotine Psychomotor Effects via Inhibition of α6-Nicotinic Receptors and Dopamine Transporters.
Williams BM; Steed ND; Woolley JT; Moedl AA; Nelson CA; Jones GC; Burris MD; Arias HR; Kim OH; Jang EY; Hone AJ; McIntosh JM; Yorgason JT; Steffensen SC
ACS Chem Neurosci; 2024 May; 15(9):1738-1754. PubMed ID: 38613458
[TBL] [Abstract][Full Text] [Related]
33. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area.
Nisell M; Nomikos GG; Svensson TH
Synapse; 1994 Jan; 16(1):36-44. PubMed ID: 8134899
[TBL] [Abstract][Full Text] [Related]
34. Functional Upregulation of α4* Nicotinic Acetylcholine Receptors in VTA GABAergic Neurons Increases Sensitivity to Nicotine Reward.
Ngolab J; Liu L; Zhao-Shea R; Gao G; Gardner PD; Tapper AR
J Neurosci; 2015 Jun; 35(22):8570-8. PubMed ID: 26041923
[TBL] [Abstract][Full Text] [Related]
35. Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety.
Nguyen C; Mondoloni S; Le Borgne T; Centeno I; Come M; Jehl J; Solié C; Reynolds LM; Durand-de Cuttoli R; Tolu S; Valverde S; Didienne S; Hannesse B; Fiancette JF; Pons S; Maskos U; Deroche-Gamonet V; Dalkara D; Hardelin JP; Mourot A; Marti F; Faure P
Neuron; 2021 Aug; 109(16):2604-2615.e9. PubMed ID: 34242565
[TBL] [Abstract][Full Text] [Related]
36. β2 nAChR Activation on VTA DA Neurons Is Sufficient for Nicotine Reinforcement in Rats.
Walker NB; Yan Y; Tapia MA; Tucker BR; Thomas LN; George BE; West AM; Marotta CB; Lester HA; Dougherty DA; Holleran KM; Jones SR; Drenan RM
eNeuro; 2023 May; 10(5):. PubMed ID: 37193602
[TBL] [Abstract][Full Text] [Related]
37. Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors.
David V; Besson M; Changeux JP; Granon S; Cazala P
Neuropharmacology; 2006 Jun; 50(8):1030-40. PubMed ID: 16580026
[TBL] [Abstract][Full Text] [Related]
38. Nicotine-induced molecular alterations are modulated by GABA
Varani AP; Pedrón VT; Aon AJ; Höcht C; Acosta GB; Bettler B; Balerio GN
Addict Biol; 2018 Jan; 23(1):230-246. PubMed ID: 28419642
[TBL] [Abstract][Full Text] [Related]
39. Nicotine self-administered directly into the VTA by rats is weakly reinforcing but has strong reinforcement enhancing properties.
Farquhar MJ; Latimer MP; Winn P
Psychopharmacology (Berl); 2012 Mar; 220(1):43-54. PubMed ID: 21894487
[TBL] [Abstract][Full Text] [Related]
40. Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments.
Besson M; Guiducci S; Granon S; Guilloux JP; Guiard B; Repérant C; Faure P; Pons S; Cannazza G; Zoli M; Gardier AM; Maskos U
Psychopharmacology (Berl); 2016 Sep; 233(18):3297-314. PubMed ID: 27385416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
